Calling for a strategic shift in drug development for childhood cancers

We are pleased to share that Nick Bird, Chair of Trustees at Solving Kids’ Cancer UK, has contributed to a new article published in The Lancet Child & Adolescent Health.

The article highlights a critical challenge facing childhood cancer research: while scientific discoveries have advanced, it still takes far too long for promising new treatments to reach children who need them. 

The authors call for a more strategic, coordinated approach to drug development, helping to accelerate the translation of discoveries from the laboratory into approved treatments for children.

Congratulations to Nick and all co-authors on this important contribution to the future of childhood cancer drug development.